These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4067219)

  • 41. [Is there a place for 2nd look laparotomy in the treatment of ovarian cancers?].
    Stöckle E; Bussières E; Stöckle M; Avril A; Thomas L; Chauvergne J; Brunet R; Pigneux J; Marée D
    Bull Cancer; 1993 Jul; 80(7):629-38. PubMed ID: 8204944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Times and sites of relapses after negative second look in advanced epithelial ovarian cancer.
    Maggino T; Gadducci A; Romagnolo C; Fanucchi A; Fioretti P
    Eur J Surg Oncol; 1994 Apr; 20(2):146-50. PubMed ID: 8181580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The validity and significance of substages of advanced ovarian cancer.
    Partridge EE; Gunter BC; Gelder MS; Alvarez RD; Soong SJ; Austin JM; Kilgore LC
    Gynecol Oncol; 1993 Feb; 48(2):236-41. PubMed ID: 8428697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bowel resections in cancers of the ovary ].
    Kauffmann P; Le Bouëdec G; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):501-8. PubMed ID: 7693794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.
    Greer BE; Bundy BN; Ozols RF; Fowler JM; Clarke-Pearson D; Burger RA; Mannel R; DeGeest K; Hartenbach EM; Baergen RN; Copeland LJ
    Gynecol Oncol; 2005 Oct; 99(1):71-9. PubMed ID: 16039699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
    Ojeda B; Llanos M; Brunet J; Lacasta A; Alonso MC; Rueda A; Delgado E; Badía J; López López JJ
    Med Clin (Barc); 1995 Feb; 104(5):165-9. PubMed ID: 7877374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
    Condra KS; Mendenhall WM; Morgan LS; Marcus RB
    Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second look laparotomy--its role in the management of ovarian carcinoma.
    Rogo KO; Ojwang SB; Stendahl U
    East Afr Med J; 1989 Dec; 66(12):844-50. PubMed ID: 2693069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic results of second-look laporatomy with extensive dissection of retroperitoneal lymph nodes in ovarian cancer patients].
    Wu X; Zhang Z; Tang M
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):300-2. PubMed ID: 11776822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of second-look operation in patients with advanced epithelial ovarian carcinoma.
    Sevelda P; Dittrich C; Salzer H
    Arch Gynecol Obstet; 1989; 244(2):79-86. PubMed ID: 2712601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical aspects of second-look laparotomy in ovarian cancer.
    Rubinstein E; Knudsen JB
    Ann Chir Gynaecol; 1986; 75(3):177-9. PubMed ID: 3740786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Morphologic evaluation of glandular inclusions in the peritoneum in relation to the prognostic value of second look laparotomy in ovarian cancer].
    Dzikonski M; Fiedler B
    Zentralbl Gynakol; 1991; 113(1):49-52. PubMed ID: 1645490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical treatment for advanced epithelial carcinoma of the ovary.
    Beller U; Beckman EM; Muggia FM; Douglas GW
    Surg Gynecol Obstet; 1987 Sep; 165(3):279-83. PubMed ID: 3629445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian cancer.
    Boyd ME
    Can J Surg; 1985 Mar; 28(2):114-6, 118. PubMed ID: 3971233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Second-look laparotomy in ovarian cancer: evaluation of pathologic variables.
    Podratz KC; Malkasian GD; Hilton JF; Harris EA; Gaffey TA
    Am J Obstet Gynecol; 1985 May; 152(2):230-8. PubMed ID: 4003469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.